Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Aug-08 8:38 PM View:  | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 24,223 | $3.00 | $72,669.00 | (100%) 24.22K to 0 | < 1% |
| 21-Aug-08 8:39 PM View: | Eastham Karin Director | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 12,500 | $3.00 | $37,500.00 | (100%) 12.5K to 0 | < 1% |
| 21-Aug-08 8:37 PM View: | Grey Michael G President & CEO Director | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 100,000 | $3.00 | $300,000.00 | (100%) 100.0K to 0 | < 1% |
| 21-Aug-08 8:37 PM View: | Burley Stephen CSO & SVP, Research | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 55,731 | $3.00 | $167,193.00 | (100%) 55.73K to 0 | < 1% |
| 27-Aug-08 5:11 PM View: | Bvf Partners L P/il 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 5,507,670 | $3.00 | $16,523,000.00 | (100%) 5.51M to 0 | < 1% |
| 22-Aug-08 5:28 PM View: | Bock Louis C Director 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition Duplicate | 2,546,750 | $3.00 | $7,640,240.00 | (100%) 2.55M to 0 | < 1% |
| 21-Aug-08 8:37 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 25,005 | $3.00 | $75,015.00 | (100%) 25.0K to 0 | < 1% |
| 21-Aug-08 8:38 PM View: | Henney Christopher S Director | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 97,165 | $3.00 | $291,495.00 | (100%) 97.17K to 0 | < 1% |
| 22-Aug-08 5:29 PM View: | Bavp, L.P. 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 20-Aug-08 | Disposition | 2,546,750 | $3.00 | $7,640,240.00 | (100%) 2.55M to 0 | < 1% |
| 18-Aug-08 3:47 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Aug-08 | Market Option Sale (Planned) | 781 | $2.98 | $2,327.38 | (3%) 25.0K to 24.22K | 0% |
| 18-Aug-08 3:47 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Aug-08 | Option Exercise | 1,562 | -- | -- | 7% 23.44K to 25.0K | |
| 06-Aug-08 1:01 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Aug-08 | Option Exercise | 1,563 | -- | -- | 6% 24.22K to 25.79K | |
| 06-Aug-08 1:01 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Aug-08 | Market Option Sale (Planned) | 781 | $2.96 | $2,311.76 | (3%) 25.79K to 25.0K | < 1% |
| 16-Jul-08 9:51 AM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Jul-08 | Option Exercise | 1,563 | -- | -- | 7% 22.66K to 24.22K | |
| 16-Jul-08 9:51 AM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Jul-08 | Market Option Sale (Planned) | 781 | $3.05 | $2,383.05 | (3%) 24.22K to 23.44K | < 1% |
| 11-Jul-08 7:31 PM View: | Bvf Partners L P/il 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 11-Jul-08 | Market Purchase | 12,500 | $3.07 | $38,372.50 | < 1% 5.5M to 5.51M | (< 1%) |
| 11-Jul-08 7:31 PM View: | Bvf Partners L P/il 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 10-Jul-08 | Market Purchase | 403,200 | $3.03 | $1,221,620.00 | 8% 5.09M to 5.5M | < 1% |
| 11-Jul-08 7:31 PM View: | Bvf Partners L P/il 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 09-Jul-08 | Market Purchase | 800,300 | $3.04 | $2,434,110.00 | 19% 4.29M to 5.09M | < 1% |
| 11-Jul-08 7:31 PM View: | Bvf Partners L P/il 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 08-Jul-08 | Purchase | 82,100 | $2.99 | $245,799.00 | 2% 4.21M to 4.29M | 2% |
| 07-Jul-08 5:21 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 07-Jul-08 | Market Option Sale (Planned) | 781 | $1.60 | $1,249.60 | (3%) 25.0K to 24.22K | 3% |
| 07-Jul-08 5:21 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 07-Jul-08 | Option Exercise | 1,562 | -- | -- | 7% 23.44K to 25.0K | |
| 20-Jun-08 4:21 PM View: | Bvf Partners L P/il 10% Owner | SGX Pharmaceuticals, Inc. (SGXP) | 18-Jun-08 | Market Purchase | 1,105,260 | $1.45 | $1,602,620.00 | 36% 3.1M to 4.21M | 16% |
| 17-Jun-08 1:44 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 16-Jun-08 | Market Option Sale (Planned) | 781 | $1.65 | $1,288.65 | (3%) 23.44K to 22.66K | (2%) |
| 17-Jun-08 1:44 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 16-Jun-08 | Option Exercise | 1,562 | -- | -- | 7% 21.88K to 23.44K | |
| 06-Jun-08 11:16 AM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Jun-08 | Market Option Sale (Planned) | 781 | $1.35 | $1,054.35 | (3%) 24.22K to 23.44K | (2%) |
| 06-Jun-08 11:16 AM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Jun-08 | Option Exercise | 1,563 | -- | -- | 7% 22.66K to 24.22K | |
| 15-May-08 8:58 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-May-08 | Market Option Sale (Planned) | 781 | $1.45 | $1,132.45 | (3%) 22.66K to 21.88K | 2% |
| 15-May-08 8:58 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-May-08 | Option Exercise | 1,563 | -- | -- | 7% 21.1K to 22.66K | |
| 06-May-08 3:00 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-May-08 | Option Exercise | 1,562 | -- | -- | 7% 21.88K to 23.44K | |
| 06-May-08 3:00 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-May-08 | Market Option Sale (Planned) | 781 | $1.43 | $1,116.83 | (3%) 23.44K to 22.66K | (108%) |
| 16-Apr-08 2:20 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Apr-08 | Option Exercise | 1,562 | -- | -- | 8% 20.32K to 21.88K | |
| 16-Apr-08 2:20 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Apr-08 | Market Option Sale (Planned) | 781 | $1.19 | $929.39 | (4%) 21.88K to 21.1K | (22%) |
| 08-Apr-08 3:46 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 07-Apr-08 | Market Option Sale (Planned) | 781 | $1.33 | $1,042.30 | (3%) 22.66K to 21.88K | (9%) |
| 08-Apr-08 3:46 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 07-Apr-08 | Option Exercise | 1,563 | -- | -- | 7% 21.1K to 22.66K | |
| 18-Mar-08 3:37 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 17-Mar-08 | Market Option Sale (Planned) | 781 | $4.01 | $3,131.81 | (4%) 21.1K to 20.32K | 64% |
| 18-Mar-08 3:37 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 17-Mar-08 | Option Exercise | 1,563 | -- | -- | 8% 19.53K to 21.1K | |
| 05-Mar-08 2:37 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Mar-08 | Market Option Sale (Planned) | 781 | $4.05 | $3,163.05 | (4%) 21.88K to 21.1K | 65% |
| 05-Mar-08 2:37 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Mar-08 | Option Exercise | 1,562 | -- | -- | 8% 20.32K to 21.88K | |
| 19-Feb-08 2:42 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Feb-08 | Market Option Sale (Planned) | 781 | $4.05 | $3,163.05 | (4%) 20.32K to 19.53K | 65% |
| 19-Feb-08 2:42 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Feb-08 | Option Exercise | 1,562 | -- | -- | 8% 18.75K to 20.32K | |
| 05-Feb-08 4:02 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Feb-08 | Option Exercise | 1,563 | -- | -- | 8% 19.53K to 21.1K | |
| 05-Feb-08 4:02 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Feb-08 | Market Option Sale (Planned) | 781 | $4.40 | $3,436.40 | (4%) 21.1K to 20.32K | 68% |
| 16-Jan-08 12:29 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Jan-08 | Option Exercise | 1,563 | -- | -- | 9% 17.97K to 19.53K | |
| 16-Jan-08 12:29 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 15-Jan-08 | Market Option Sale (Planned) | 781 | $4.44 | $3,467.64 | (4%) 19.53K to 18.75K | 68% |
| 07-Jan-08 3:14 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 07-Jan-08 | Market Option Sale (Planned) | 781 | $5.15 | $4,022.15 | (4%) 20.32K to 19.53K | 72% |
| 07-Jan-08 3:14 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 07-Jan-08 | Option Exercise | 1,562 | -- | -- | 8% 18.75K to 20.32K | |
| 18-Dec-07 12:58 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 17-Dec-07 | Market Option Sale (Planned) | 781 | $4.75 | $3,709.75 | (4%) 18.75K to 17.97K | 70% |
| 18-Dec-07 12:58 PM View: | Reich Siegfried VP, Drug Discovery | SGX Pharmaceuticals, Inc. (SGXP) | 17-Dec-07 | Option Exercise | 1,562 | -- | -- | 9% 17.19K to 18.75K | |
| 05-Dec-07 8:00 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Dec-07 | Market Option Sale (Planned) | 781 | $4.85 | $3,787.85 | (4%) 19.53K to 18.75K | 71% |
| 05-Dec-07 8:00 PM View: | Myers W Todd CFO | SGX Pharmaceuticals, Inc. (SGXP) | 05-Dec-07 | Option Exercise | 1,563 | -- | -- | 9% 17.97K to 19.53K |
